News

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...
The study, published in the journal Food Science & Nutrition, mentions that instant coffees can increase your risk of getting ...
A combination of genetics and drinking instant coffee is linked to an increased risk of developing a common form of ...
HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud ...
Notal Vision, a digital healthcare provider advancing remote patient monitoring in ophthalmology, announced the publication ...
In this video from Clinical Trials at the Summit, Carl D. Regillo, MD, FACS, discusses the use of tyrosine kinase inhibitors for wet age-related macular degeneration and diabetic retinopathy with ...
Approximately 200 million people globally live with age-related macular degeneration (AMD), with the majority affected by its ...
Global ophthalmologists and industry experts have called for innovation and advancement of global ophthalmic technology, as ...
This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...
Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...
A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration ...
Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which obtained a groundbreaking FDA clearance late last year. | LumiThera's approach ...